ArticleFrontiers in cardiovascular medicine2022

Impact of early PCSK9 inhibitor treatment on heart after percutaneous coronary intervention in patients with STEMI: Design and rationale of the PERFECT II trial.

Jiachun Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.